Researchers are exploring the use of mRNA vaccines to boost the immune response against glioblastoma, a type of brain cancer. Some studies suggest that these vaccines may enhance the effectiveness of cancer immunotherapy, potentially leading to new treatment approaches. The development of personalized cancer vaccines is also being investigated, with some findings indicating promise against aggressive forms of the disease.